These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 27520486

  • 1. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling.
    Vecchio EA, Chuo CH, Baltos JA, Ford L, Scammells PJ, Wang BH, Christopoulos A, White PJ, May LT.
    Biochem Pharmacol; 2016 Oct 01; 117():46-56. PubMed ID: 27520486
    [Abstract] [Full Text] [Related]

  • 2. Capadenoson, a clinically trialed partial adenosine A1 receptor agonist, can stimulate adenosine A2B receptor biased agonism.
    Baltos JA, Vecchio EA, Harris MA, Qin CX, Ritchie RH, Christopoulos A, White PJ, May LT.
    Biochem Pharmacol; 2017 Jul 01; 135():79-89. PubMed ID: 28344125
    [Abstract] [Full Text] [Related]

  • 3. Characterisation of endogenous A2A and A2B receptor-mediated cyclic AMP responses in HEK 293 cells using the GloSensor™ biosensor: Evidence for an allosteric mechanism of action for the A2B-selective antagonist PSB 603.
    Goulding J, May LT, Hill SJ.
    Biochem Pharmacol; 2018 Jan 01; 147():55-66. PubMed ID: 29106905
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tritium-labeled agonists as tools for studying adenosine A2B receptors.
    Hinz S, Alnouri WM, Pleiss U, Müller CE.
    Purinergic Signal; 2018 Sep 01; 14(3):223-233. PubMed ID: 29752618
    [Abstract] [Full Text] [Related]

  • 6. VCP746, a novel A1 adenosine receptor biased agonist, reduces hypertrophy in a rat neonatal cardiac myocyte model.
    Chuo CH, Devine SM, Scammells PJ, Krum H, Christopoulos A, May LT, White PJ, Wang BH.
    Clin Exp Pharmacol Physiol; 2016 Oct 01; 43(10):976-82. PubMed ID: 27377874
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation.
    Vecchio EA, Tan CY, Gregory KJ, Christopoulos A, White PJ, May LT.
    J Pharmacol Exp Ther; 2016 Apr 01; 357(1):36-44. PubMed ID: 26791603
    [Abstract] [Full Text] [Related]

  • 9. BAY60-6583 acts as a partial agonist at adenosine A2B receptors.
    Hinz S, Lacher SK, Seibt BF, Müller CE.
    J Pharmacol Exp Ther; 2014 Jun 01; 349(3):427-36. PubMed ID: 24633424
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A(2A) receptor agonist and adenosine A(3) receptor antagonist activity.
    Bevan N, Butchers PR, Cousins R, Coates J, Edgar EV, Morrison V, Sheehan MJ, Reeves J, Wilson DJ.
    Eur J Pharmacol; 2007 Jun 14; 564(1-3):219-25. PubMed ID: 17382926
    [Abstract] [Full Text] [Related]

  • 11. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF, Schiedel AC, Thimm D, Hinz S, Sherbiny FF, Müller CE.
    Biochem Pharmacol; 2013 May 01; 85(9):1317-29. PubMed ID: 23500543
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
    Thimm D, Schiedel AC, Sherbiny FF, Hinz S, Hochheiser K, Bertarelli DC, Maass A, Müller CE.
    Biochemistry; 2013 Jan 29; 52(4):726-40. PubMed ID: 23286920
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activation of A2b adenosine receptor regulates ovarian cancer cell growth: involvement of Bax/Bcl-2 and caspase-3.
    Hajiahmadi S, Panjehpour M, Aghaei M, Shabani M.
    Biochem Cell Biol; 2015 Aug 29; 93(4):321-9. PubMed ID: 25877700
    [Abstract] [Full Text] [Related]

  • 16. Activation of adenosine A2A or A2B receptors causes hypothermia in mice.
    Carlin JL, Jain S, Duroux R, Suresh RR, Xiao C, Auchampach JA, Jacobson KA, Gavrilova O, Reitman ML.
    Neuropharmacology; 2018 Sep 01; 139():268-278. PubMed ID: 29548686
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A(2b) receptor mediates adenosine inhibition of taurine efflux from pituicytes.
    Pierson PM, Peteri-Brunbäck B, Pisani DF, Abbracchio MP, Mienville JM, Rosso L.
    Biol Cell; 2007 Aug 01; 99(8):445-54. PubMed ID: 17391106
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.
    Varani K, Gessi S, Merighi S, Vincenzi F, Cattabriga E, Benini A, Klotz KN, Baraldi PG, Tabrizi MA, Lennan SM, Leung E, Borea PA.
    Biochem Pharmacol; 2005 Nov 25; 70(11):1601-12. PubMed ID: 16219300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.